Equity Capital Markets
Our Approach
A successful capital markets transaction needs to achieve its financial objectives within the financial and legal parameters in this jurisdiction and globally. We are renowned for providing innovative advice on equity capital markets, new and existing financial structures and financial products. We have acted for many listed corporations in their equity capital markets transactions and have excellent working relationships with the Australian Securities & Investments Commission, the Australian Securities Exchange and the Australian Prudential Regulatory Authority.
Our team has a deep understanding of the specific requirements and approaches taken by issuers, underwriters and “cornerstone” investors in initial public offering (IPO) transactions. We also act on difficult and strategic capital management matters, including advising listed companies looking to undertake on-market buy-backs, entitlement offers or underwritten dividend reinvestment plans.
Our Equity Capital Market services include:
- Conducting initial public offerings.
- Establishing and structuring listed and unlisted managed funds.
- Advising on subsequent offerings including rights issues (including accelerated entitlement offers), private placements, share purchase plans, DRP underwritings and on the establishment of share and interest sale facilities.
- Advising on block trades.
- Advising on the structuring of complex capital instruments, such as debenture and hybrid offerings.
- Advising on capital management strategies, including buy-backs and capital reductions.
- Debt capital markets and securitisation – on various programme establishments, drawdowns, credit-wrapped notes, US private placements and Islamic bonds.
Our Experience
Our Equity Capital Market experience includes advising:
- Pepper Money on its IPO and ASX listing.
- Australian Clinical Labs on its IPO and ASX listing.
- Peter Warren Automotive Group on its IPO and ASX listing.
- Goldman Sachs and UBS as joint lead managers and underwriters of Bank of Queensland's ~$1.325 billion placement and ANREO.
- Morgan Stanley and Goldman Sachs as joint lead managers and underwriters of Carsales.com’s $600 million PAITREO to fund the acquisition of Trader Interactive.
- Adore Beauty on its IPO and ASX listing.
- CleanSpace on its IPO and ASX listing.
- Universal Store on its IPO and ASX listing.
- UBS as underwriter of the $600 million PAITREO conducted by Tabcorp Holdings Limited.
- Goldman Sachs, Credit Suisse, Citi and Bell Potter as underwriters of the $250 million placement plus ANREO conducted by Coronado Global Resources Inc.
- J.P. Morgan as the sole lead manager and underwriter of Ramsay Health Care Limited’s $1.2 billion placement and share purchase plan.
- Viva Energy Group Limited on its IPO and listing on the ASX - the largest IPO in Australia for four years and the largest non-government IPO in Australian corporate history.
- SiteMinder on its capital raising from international and Australian investors which saw it become another Australian unicorn.
- J.P. Morgan as the sole lead manager and underwriter of Ramsay Health Care Limited’s $1.2 billion placement and share purchase plan.
- Nitro Software on its IPO and listing on the ASX.
- Xero Limited in respect of its Convertible Note offering to raise $US300 million and associated call option transactions.
- MoneyMe on its IPO and listing on ASX.
- Credit Suisse and Macquarie Capital as lead managers and underwriters of the $1.2 billion accelerated non-renounceable entitlement offer by Vicinity Centres.
- Velocity Frequent Flyer on its proposed IPO and listing on ASX.
- Credit Suisse, Goldman Sachs and J.P. Morgan, the joint lead managers and bookrunners of HomeConsortium’s $300 million IPO and ASX listing.
- Yancoal Australia Ltd on its dual primary listing on the Main Board of the Hong Kong Stock Exchange and associated capital raising (including Australian rights offering and Hong Kong IPO).
- Syrah Resources innovative $110 million capital raising involving convertible note issue to AustralianSuper.
- Tyro Payments on its IPO and listing on the ASX.
- Morgan Stanley and UBS as joint lead managers of a $1.35 billion entitlement offer and placement by Atlas Arteria.
- Goldman Sachs and J.P. Morgan as joint lead managers and underwriters of the $1.2 billion placement by QBE Insurance Group Limited.
- Goldman Sachs, UBS, Credit Suisse and Bell Potter as joint lead managers of Coronado Global Resources Inc.'s $774 million IPO and ASX listing.
- Goldman Sachs as sale agent for the share sale facility established in connection with the $16 billion demerger of Coles Group Limited from Wesfarmers.
- Beach Energy on its equity capital raising and debt financing to fund its $1.585 billion acquisition of Lattice Energy.
- Sonic Healthcare Limited on its fully-underwritten $600 million institutional placement and non-underwritten $100 million share purchase plan to fund its $750 million acquisition of US-based Aurora Diagnostics.
- Telstra on its $1.25 billion off-market share buy-back.
- Macquarie Capital, UBS, CIMB, Credit Suisse, Goldman Sachs and Merrill Lynch as the joint lead managers on Healthscope’s $3.6 billion IPO.
Awards + Recognition
Ranked Band 1 in Equity Capital Markets.
G+T is ranked Tier 1 in Capital markets: Equity.
Named Law Firm of the Year for Corporate Law.
Ranked Tier 1 in Equity Capital Markets.
Named Law Firm of the Year for Corporate Law and for Private Equity Law.
G+T was awarded Best Law & Related Services Firm, Most Innovative Firm and Best Provider to Mining, Oil & Gas.
Ranked 1st Tier for Corporate Law.
G+T was named Law Firm of the Year (101-500 lawyers).
G+T was named Australian Firm of the Law.
G+T won Most Innovative Team in Asia-Pacific.
G+T was awarded Best IPO and Best New Zealand Deal.
G+T advised on the Equity Securities Deal of the Year.
G+T advised on the Capital Markets Deal of the Year.
Ranked an ‘Outstanding’ firm in the Asialaw Profiles 2019. Also ranked ‘Outstanding’ in Capital Markets.